FDG-PET predicts treatment efficacy and surgical outcome of pre-operative chemoradiation therapy for resectable and borderline resectable pancreatic cancer
Hirofumi Akita(The University of Osaka), Masato Sakon(Osaka University), Masayuki Ohue(Hyogo Medical University), Norikatsu Miyoshi(Osaka International Cancer Institute), Hiroshi Miyata(Osaka University), Osamu Ishikawa(Gunma University), Jin‐Hwa Moon(Hanyang University), Akira Tomokuni(Apple (Israel)), Hiroaki Ohigashi(Teine Keijinkai Hospital), Hidenori Takahashi(Osaka International Cancer Institute), Yasuhiro Fujiwara(Yokohama City University), Keijiro Sugimura(Osaka International Cancer Institute), Masayoshi Yasui(Osaka International Cancer Institute), Masahiko Yano(Nagoya Sangyo University), Takeshi Omori(Osaka International Cancer Institute), Shogo Kobayashi(Osaka Gakuin University)
Cited by 52
Related Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
|Journal of Clinical Oncology|2010|1.6k
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
An antitumor promoter from Moringa oleifera Lam.
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|1999|404
Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study
|Cancer Science|2019|375
Practical Usefulness of Lymphatic and Connective Tissue Clearance for the Carcinoma of the Pancreas Head
|Annals of Surgery|1988|373